Guggenheim Capital LLC Bristol Myers Squibb CO Transaction History
Guggenheim Capital LLC
- $12 Billion
- Q4 2024
A detailed history of Guggenheim Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Guggenheim Capital LLC holds 723,676 shares of BMY stock, worth $35.4 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
723,676
Previous 721,278
0.33%
Holding current value
$35.4 Million
Previous $37.3 Million
9.66%
% of portfolio
0.34%
Previous 0.27%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,780Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.3 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.76 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.7 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.66 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$2.95 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...